Sign in Subscribe
5 min read sma20-sma50-strategy

EverHint – SMA20 × SMA50 Crossover Signals for Jan 23, 2026 – Healthcare Leads with 12 Setups

47 signals. Healthcare leads (12). 15 with insider selling. 1 with insider buying. 3 with congressional buying. 1 with congressional selling. price range $6-$662. RSI 19-90. sectors: Healthcare (12), Technology (12), Industrials (7). 31.9% have news.

What This Signal Is (Quick)

This strategy detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50):

  • Buy Signal (SMA20_x_SMA50_Buy) - "Golden Cross": SMA(20) crosses above SMA(50) on today's close

    • Short-term momentum (20 days) exceeds medium-term trend (50 days)
    • Bullish trend confirmation with high reliability
    • Ideal for medium-term trend following (4-12 week holding periods)

  • Sell Signal (SMA20_x_SMA50_Sell) - "Death Cross": SMA(20) crosses below SMA(50) on today's close

    • Short-term momentum weakens below medium-term trend
    • Bearish trend confirmation
    • Can signal exit points or trend reversal alerts

Key Characteristics:

  • Uses two SMAs (both simple moving averages) for maximum stability
  • Most stable strategy - fewer signals but highest quality (fewer whipsaws)
  • Better suited for medium-term trends with confirmed momentum
  • Lower risk entries compared to faster EMA-based strategies

Key Criteria:

  • Buy: SMA20 crosses above SMA50

  • Sell: SMA20 crosses below SMA50

  • Minimum ADV: $40M (liquidity filter)

  • Earnings buffer: 7 days pre/post earnings

  • Fresh crossover: Detected on today's close

Holding Period: 2-6 weeks
Risk Level: Medium

How We Ranked Today

Ranked by RSI (lower RSI = more oversold for buy signals)

📊 SMA20 × SMA50 Crossover Signals (Top 15 of 47 total)

Ranked by rsi14:

Rank Ticker Company Sector Last ($) RSI14 Insider Net Days → Earnings Est EPS Mkt Cap ($B)
1 HCI HCI Group, Inc. Financial Services 158.50 19.0 — 34 $16.25 2.1
2 HPE Hewlett Packard Enterp... Technology 21.05 22.5 $-2.0M 41 $3.34 28.1
3 WST West Pharmaceutical Se... Healthcare 236.66 23.0 — 89 $10.72 17.0
4 GNW Genworth Financial Inc Financial Services 8.14 23.6 — 24 $0.64 3.3
5 HIG Hartford Financial Ser... Financial Services 128.62 23.9 — 89 $15.12 35.8
6 BRZE Braze, Inc. Technology 25.12 24.6 $-2.0M 62 $0.98 2.6
7 CHDN Churchill Downs, Incor... Consumer Cyclical 102.54 31.1 — 88 $9.03 7.1
8 CART Maplebear Inc. Consumer Cyclical 39.90 31.5 — 32 $3.09 10.5
9 ISRG Intuitive Surgical, Inc. Healthcare 523.99 32.1 $-3.5M 87 $14.81 187.8
10 APP Applovin Corporation Technology 524.41 32.2 $-286K 19 $34.38 177.4
11 PEGA Pegasystems Inc. Technology 50.38 36.4 $-1.6M 87 $1.73 8.6
12 BCRX BioCryst Pharmaceutica... Healthcare 6.79 37.5 — 31 $1.35 1.4
13 ADMA ADMA Biologics Inc Healthcare 16.73 38.1 $-215K 38 $1.95 4.0
14 XENE Xenon Pharmaceuticals ... Healthcare 41.76 40.8 — 34 $1.00 3.2
15 EW Edwards Lifesciences C... Healthcare 83.65 44.0 $-917K 88 $4.08 49.1

Field Notes

Sector concentration: Healthcare (12), Technology (12), Industrials (7)

Insider selling: SNX (TD SYNNEX Corporation, $-1.8M), PSX (Phillips 66, $-10.0M), PLTR (Palantir Technologies Inc., $-9.7M)

Insider buying: GPN (Global Payments Inc., $+1.1M)

Data coverage: 34.0% insider, 8.5% congressional (1 recent/90d, 3 older/1y), 91.5% earnings, 97.9% analyst, 31.9% news

Congressional Activity

NKE (Nike, Inc.) 🔴 Bearish (1y)

  • 1 sale by 1 member
  • Pattern: 1 full liquidation
  • Top seller: Sen. Shelley Moore Capito (WV) - 1 transaction ($1,001 - $15,000), 1 full liquidation

AMD (Advanced Micro Devices, Inc.) 🟢 Bullish (1y)

  • 1 purchase by 1 member
  • Top buyer: Ashley Moody - 1 transaction ($100,001 - $250,000)

ISRG (Intuitive Surgical, Inc.) 🟢 Bullish (1y)

  • 1 purchase by 1 member
  • Top buyer: Sen. Markwayne Mullin (OK) - 1 transaction ($50,001 - $100,000)

VVV (Valvoline Inc.) 🟢 Bullish (90d)

  • 1 purchase by 1 member
  • Top buyer: Hou. Michael McCaul (TX) - 1 transaction ($15,001 - $50,000)

Recent Headlines

ADMA (ADMA Biologics Inc)

  • ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? (source)

APP (Applovin Corporation)

  • AppLovin (NASDAQ: APP) Stock Price Prediction and Forecast 2026-2030 (Jan 23) (source)
  • A Once-in-a-Decade Investment Opportunity: The 2 Best AI Stocks to Buy Now (source)
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AppLovin Corporation - APP (source)
  • AppLovin's Price Volatility is a Feature, Not a Business Fall (source)
  • AppLovin's Path To $700 (source)
  • AppLovin Shares Drop As Stock Market Slides, Investigative Report Circulates (UPDATED) (source)
  • AppLovin rejects short-seller claims of laundering ties as stock slides (source)
  • AppLovin Corporation $APP is Dilation Capital Management LP’s 7th Largest Position (source)
  • AppLovin (APP) Stock Slides as Market Rises: Facts to Know Before You Trade (source)
  • Why AppLovin Stock Was Falling Today (source)
  • Wall Street Is Down on Software Stocks. This Expert Says That's 'Absolutely Wrong' (source)
  • AppLovin Or Shopify: Which Stock To Bet On? (source)
  • Brokers Suggest Investing in AppLovin (APP): Read This Before Placing a Bet (source)
  • AppLovin's Scalable Ad Engine Emerges as the Real Growth Catalyst (source)
  • AppLovin (NASDAQ: APP) Stock Price Prediction and Forecast 2026-2030 (Jan 16) (source)

BCRX (BioCryst Pharmaceuticals, Inc.)

  • BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema (source)
  • Analyzing BioCryst Pharmaceuticals (NASDAQ:BCRX) and Prelude Therapeutics (NASDAQ:PRLD) (source)

HIG (Hartford Financial Services Gro)

  • The Hartford Insurance Group, Inc. $HIG Shares Sold by AMF Tjanstepension AB (source)

ISRG (Intuitive Surgical, Inc.)

  • Amalgamated Bank Has $36.96 Million Stock Position in Intuitive Surgical, Inc. $ISRG (source)
  • Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results (source)
  • Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder (source)
  • Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet (source)
  • Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (source)
  • Surging Intel Stock, 2 Other Nasdaq 100 Giants Headline Earnings Calendar (source)

WST (West Pharmaceutical Services, I)

  • West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack (source)

Market Context

The broader market exhibits mixed performance with the S&P 500 edging up 0.11% and the Nasdaq gaining 0.26%, signaling modest bullish momentum in growth-oriented segments, while the Dow Jones dipped 0.34%, reflecting caution in more cyclical areas. This divergence points to a trend direction that is tentatively upward but lacks conviction, potentially curbing aggressive risk appetite among traders. For SMA20/SMA50 crossover signals, which rely on sustained trend confirmation, such uneven breadth could delay reliable setups, favoring patience amid choppy price action.

Elevated VIX at 16.09, up 2.61%, underscores rising volatility that amplifies intraday swings, heightening the risk of whipsaws for shorter-term moving average strategies like SMA20/SMA50. In this environment, signals may trigger prematurely on noise rather than genuine momentum shifts, advising tighter stops and confirmation from volume or higher timeframes to filter false crossovers.

With 47 total signals and Healthcare as the top sector, current conditions suggest sector rotation toward defensive plays, bolstered by the S&P's resilience despite Dow weakness. This implies SMA strategies could thrive in Healthcare on relative strength, but broader risk-off undertones from volatility may pressure signals in underperforming areas, emphasizing selective execution.

⚠️ Extended Non-Trading Period Alert

Important: The next 2 days (Saturday, January 24 through Sunday, January 25) are non-trading days (weekend/holiday).

What this means:

  • Markets will not reopen until Monday, January 26
  • News and events occurring over this extended non-trading period may significantly influence market sentiment
  • Monitor news flow closely during this period
  • Be prepared for potential gaps or increased volatility when markets reopen
  • Earnings announcements, geopolitical events, or major news during this period can lead to significant price movements at the open
  • Consider adjusting position sizes or using protective stops given the extended gap risk

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Healthcare (12 signals) suggests sector-specific rotation. 1 signal with insider buying adds conviction. 15 signals showing insider selling warrant caution. 3 signals with congressional buying (90-day) shows lawmaker confidence.

Sharing Call-to-Action

✅ If this added value to your research, consider liking, sharing, or subscribing. It genuinely helps.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

Published by:

Vladimir Shamgin

You might also like...

25
Jan

EverHint – Momentum Swing — Breakout Standard Signals for Jan 23, 2026 – Basic Materials Leads with 10 Setups

33 signals. Basic Materials leads (10). 7 with insider selling. 1 with insider buying. price range $6-$453. sectors: Basic Materials (10), Healthcare (8), Financial Services (4). 1 report earnings within 7 days. full analyst coverage, 45.5% have news.
5 min read
25
Jan

EverHint – Momentum Swing — Explosive Volume Breakout Signals for Jan 23, 2026 – Consumer Cyclical Leads with 2 Setups

3 signals. Consumer Cyclical leads (2). 1 with insider selling. price range $100-$453. sectors: Consumer Cyclical (2), Financial Services (1). full analyst coverage, earnings data, 66.7% have news.
2 min read
25
Jan

EverHint – EMA10 × Price × MACD Signals for Jan 23, 2026 – Consumer Cyclical Leads with 2 Setups

6 signals. Consumer Cyclical leads (2). 3 with insider selling. price range $17-$309. RSI 55-81. sectors: Consumer Cyclical (2), Healthcare (2), Technology (1). full analyst coverage, earnings data, 50.0% have news.
3 min read
25
Jan

EverHint – EMA10 × EMA30 Crossover Signals for Jan 23, 2026 – Technology Leads with 10 Setups

50 signals. Technology leads (10). 13 with insider selling. 1 with insider buying. 2 with congressional buying. 2 with congressional selling. price range $6-$820. RSI 26-81. sectors: Technology (10), Consumer Cyclical (8), Healthcare (8). 2 report earnings within 7 days.
12 min read
25
Jan

EverHint – Dip & Bounce Mean Reversion Signals for Jan 23, 2026 – Technology Leads with 16 Setups

27 signals. Technology leads (16). AA dips 8.9%. avg 4.3% dip, 3.6% bounce. 14 with insider selling. 1 with insider buying. 1 with congressional selling. price range $7-$473. RSI 26-88. sectors: Technology (16), Healthcare (4), Consumer Cyclical (3). 1 report earnings within 7 days.
5 min read